Literature DB >> 16433073

Effects of experimental increases and decreases in thyroxine levels on the extent of cataleptic freezing reactions in rats.

A V Kulikov1, M A Tikhonova, E I Lebedeva, V F Chugui, N K Popova.   

Abstract

Numerous clinical observations have provided evidence for a tight connection between impairments in the functions of the hypothalamo-hypophyseal-thyroid system and nervous and mental disorders. The aim of the present work was to compare the effects of experimental decreases and increases in blood thyroxine levels on the extents of two types of pathological freezing reaction in male Wistar rats--spontaneous catalepsy and catalepsy evoked by pinches at the nape of the neck (pinch-induced catalepsy). Chronic administration of the thyroxine synthesis inhibitor propylthiouracil (5 mg/kg/day for 28 days) significantly decreased the blood hormone level and sharply increased the proportion of animals showing spontaneous catalepsy and the immobility time, but had no effect on the extent of pinch-induced catalepsy. At the same time, chronic administration of thyroxine (0.1 mg/kg/day for 28 days), which produced significant increases in blood hormone levels, had no effect on the extent of spontaneous catalepsy but significantly increased the proportion of animals showing pinch-induced catalepsy and the duration of this type of catalepsy. It is concluded that both insufficiency and excess of thyroid hormones have cataleptogenic actions, but enhance different types of catalepsy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16433073     DOI: 10.1007/s11055-005-0121-2

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  18 in total

Review 1.  Novel uses of thyroid hormones in patients with affective disorders.

Authors:  A J Prange
Journal:  Thyroid       Date:  1996-10       Impact factor: 6.568

Review 2.  The catalepsy test: its ups and downs.

Authors:  P R Sanberg; M D Bunsey; M Giordano; A B Norman
Journal:  Behav Neurosci       Date:  1988-10       Impact factor: 1.912

3.  Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates.

Authors:  M Zhang; I Creese
Journal:  Neurosci Lett       Date:  1993-10-29       Impact factor: 3.046

Review 4.  Drug effects on active immobility responses: what they tell us about neurotransmitter systems and motor functions.

Authors:  W R Klemm
Journal:  Prog Neurobiol       Date:  1989       Impact factor: 11.685

5.  Effects of thyroid hormone deficiency on behavior in rat strains with different predisposition to catalepsy.

Authors:  N N Barykina; V F Chuguy; T A Alekhina; V G Kolpakov; A V Maksiutova; A V Kulikov
Journal:  Physiol Behav       Date:  2002-04-15

Review 6.  Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat.

Authors:  M L Wadenberg
Journal:  Neurosci Biobehav Rev       Date:  1996       Impact factor: 8.989

7.  Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat.

Authors:  H F Escobar-Morreale; F E del Rey; M J Obregón; G M de Escobar
Journal:  Endocrinology       Date:  1996-06       Impact factor: 4.736

8.  On the role of brain serotonin in expression of genetic predisposition to catalepsy in animal models.

Authors:  N K Popova; A V Kulikov
Journal:  Am J Med Genet       Date:  1995-06-19

9.  Neuroendocrine evidence for an association between hypothyroidism, reduced central 5-HT activity and depression.

Authors:  A J Cleare; A McGregor; V O'Keane
Journal:  Clin Endocrinol (Oxf)       Date:  1995-12       Impact factor: 3.478

10.  Inheritance of predisposition to catalepsy in mice.

Authors:  A V Kulikov; E Y Kozlachkova; G B Maslova; N K Popova
Journal:  Behav Genet       Date:  1993-07       Impact factor: 2.805

View more
  1 in total

1.  Chronic administration of imipramine normalizes decreased sexual motivation and increased predisposition to catalepsy induced by propylthiouracil in rats.

Authors:  M A Tikhonova; T G Amstislavskaya; A V Kulikov
Journal:  Neurosci Behav Physiol       Date:  2009-04-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.